北陆药业：世和基因经营业绩稳定

Group 1 - The core viewpoint of the article indicates that Beilu Pharmaceutical (300016) reported stable operating performance for Shihe Gene, with operating profits showing an upward trend [1] Group 2 - The company responded to investor inquiries on July 29, emphasizing the importance of consulting the company or its disclosed information for specific operational details [1]